Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Summary
This study aims to compare different ovulation triggering strategies in women with low ovarian reserve undergoing fresh in vitro fertilization (IVF) cycles. Ovulation triggering is a key step in IVF treatment, as it determines final oocyte maturation prior to oocyte retrieval. Participants are randomly assigned to one of three ovulation trigger approaches: human chorionic gonadotropin (hCG) alone, follitropin delta combined with hCG, or dual trigger using a gonadotropin-releasing hormone (GnRH) agonist plus hCG. The primary objective is to evaluate wether adding follitropin delta at the time of triggering increases the number of matura oocytes obtained, without adversely affecting implantation rates. Pregnancy otucomes following fresh embryo transfer will also be assessed. The results of this study may help optimize ovulation triggering strategies in women with low ovarian reserve undergoing IVF treatment.
Official title: Ovulation Trigger Strategies in Women With Low Ovarian Reserve Undergoing Fresh In Vitro Fertilization Cycles: A Prospective Randomized Controlled Trial (TRIGGERBEST)
Key Details
Gender
FEMALE
Age Range
18 Years - 42 Years
Study Type
INTERVENTIONAL
Enrollment
126
Start Date
2024-09-17
Completion Date
2028-01-01
Last Updated
2026-09-11
Healthy Volunteers
No
Conditions
Interventions
Human chorionic gonadotropin (hCG)
Human chorionic gonadotropin (hCG) administered for final oocyte maturation and ovulation triggering.
Follitropin delta
Follitropin delta administered as part of the ovulation-triggering regimen for final oocyte maturation. (hCG).
Triptorelin
Triptorelin, a gonadotropin-releasing hormone (GnRH) agonist, administered as part of the ovulation-triggering regimen for final oocyte maturation.
Locations (1)
Hospital Clínico Universitario de Valencia
Valencia, Spain